Financial Statement
| Year Ending Dec 2018 (Update) | Year Ending Dec 2017 (Update) | Year Ending Dec 2016 (Update) | Year Ending Dec 2015 (Update) | |
|---|---|---|---|---|
| Net Sales | 63.39 | 57.30 | 53.28 | 55.35 |
| Revenue | 63.39 | 57.30 | 53.28 | 55.35 |
| Total Revenue | 63.39 | 57.30 | 53.28 | 55.35 |
| Cost of Revenue | 64.97 | 53.60 | 46.53 | 46.41 |
| Cost of Revenue, Total | 64.97 | 53.60 | 46.53 | 46.41 |
| Gross Profit | -1.58 | 3.70 | 6.75 | 8.94 |
| Selling/General/Administrative Expense | 23.08 | 23.30 | 21.12 | 19.08 |
| Selling/General/Administrative Expenses, Total | 23.08 | 23.30 | 21.12 | 19.08 |
| Research & Development | 6.74 | 6.32 | 5.84 | 4.96 |
| Litigation | 1.03 | -- | -- | -- |
| Unusual Expense (Income) | 1.03 | -- | -- | -- |
| Total Operating Expense | 95.83 | 83.22 | 73.49 | 70.45 |
| Operating Income | -32.44 | -25.92 | -20.21 | -15.10 |
| Interest Expense - Non-Operating | -- | 0.00 | 0.00 | 0.00 |
| Interest Expense, Net Non-Operating | -- | 0.00 | 0.00 | 0.00 |
| Interest Income, Non-Operating | 0.54 | -- | -- | -- |
| Investment Income, Non-Operating | 0.00 | 0.00 | -- | -- |
| Interest/Investment Income, Non-Operating | 0.54 | 0.00 | -- | -- |
| Interest Income (Expense), Net Non-Operating | -0.22 | 0.00 | 0.81 | 0.68 |
| Interest Income (Expense), Net-Non-Operating, Total | 0.31 | 0.00 | 0.81 | 0.68 |
| Other Non-Operating Income (Expense) | 0.00 | -- | -- | -- |
| Other, Net | 0.00 | -- | -- | -- |
| Net Income Before Taxes | -32.13 | -25.92 | -19.40 | -14.42 |
| Income Tax – Total | -- | 0.00 | 0.40 | 0.00 |
| Income After Tax | -32.13 | -25.92 | -19.80 | -14.42 |
| Net Income Before Extraordinary Items | -32.13 | -25.92 | -19.80 | -14.42 |
| Net Income | -32.13 | -25.92 | -19.80 | -14.42 |
| Income Available to Common Excluding Extraordinary Items | -32.13 | -25.92 | -19.80 | -14.42 |
| Income Available to Common Stocks Including Extraordinary Items | -32.13 | -25.92 | -19.80 | -14.42 |
| Basic Weighted Average Shares | 52.82 | 51.07 | 50.68 | 50.07 |
| Basic EPS Excluding Extraordinary Items | -0.61 | -0.51 | -0.39 | -0.29 |
| Basic EPS Including Extraordinary Items | -0.61 | -0.51 | -0.39 | -0.29 |
| Dilution Adjustment | -- | 0.00 | 0.00 | -- |
| Diluted Net Income | -32.13 | -25.92 | -19.80 | -14.42 |
| Diluted Weighted Average Shares | 52.82 | 51.07 | 50.68 | 50.07 |
| Diluted EPS Excluding Extraordinary Items | -0.61 | -0.51 | -0.39 | -0.29 |
| Diluted EPS Including Extraordinary Items | -0.61 | -0.51 | -0.39 | -0.29 |
| DPS - Common Stock Primary Issue | -- | -- | -- | 0.00 |
| Gross Dividends - Common Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Special Items | 1.03 | -- | -- | -- |
| Normalized Income Before Taxes | -31.10 | -25.92 | -19.40 | -14.42 |
| Effect of Special Items on Income Taxes | 0.00 | -- | -- | -- |
| Income Taxes Excluding Impact of Special Items | 0.00 | 0.00 | 0.40 | 0.00 |
| Normalized Income After Taxes | -31.10 | -25.92 | -19.80 | -14.42 |
| Normalized Income Available to Common | -31.10 | -25.92 | -19.80 | -14.42 |
| Basic Normalized EPS | -0.59 | -0.51 | -0.39 | -0.29 |
| Diluted Normalized EPS | -0.59 | -0.51 | -0.39 | -0.29 |
| Amortization of Intangibles, Supplemental | 0.00 | 0.00 | 0.16 | 0.17 |
| Depreciation, Supplemental | 0.65 | 0.51 | 0.60 | 0.66 |
| Interest Expense, Supplemental | -- | 0.00 | 0.00 | 0.00 |
| Rental Expense, Supplemental | 2.37 | 2.46 | 2.37 | 2.30 |
| Stock-Based Compensation, Supplemental | 4.39 | 6.95 | 10.35 | 8.89 |
| Research & Development Expense, Supplemental | 6.74 | 6.32 | 5.84 | 4.96 |
| Audit-Related Fees, Supplemental | 0.99 | 0.00 | 0.21 | 0.21 |
| Audit-Related Fees | 0.00 | 0.00 | 0.01 | 0.01 |
| Tax Fees, Supplemental | 0.00 | 0.00 | 0.11 | 0.13 |
| All Other Fees Paid to Auditor, Supplemental | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Margin | -2.50 | 6.46 | 12.67 | 16.15 |
| Operating Margin | -51.18 | -45.24 | -37.93 | -27.28 |
| Pretax Margin | -50.68 | -45.24 | -36.41 | -26.05 |
| Net Profit Margin | -50.68 | -45.24 | -37.16 | -26.05 |
| Normalized EBIT | -31.41 | -25.92 | -20.21 | -15.10 |
| Normalized EBITDA | -30.76 | -25.41 | -19.45 | -14.28 |
In millions of USD (except for per share items)
Copyright Thomson Reuters Corporation